| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3858977 | The Journal of Urology | 2016 | 6 Pages |
Abstract
Tolvaptan increases urine volume and decreases urinary supersaturation in calcium stone formers. Further study is needed to determine if long-term use of V2 receptor antagonists results in fewer stone events.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Wisit Cheungpasitporn, Stephen B. Erickson, Andrew D. Rule, Felicity Enders, John C. Lieske,